# Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

> **NCT01093196** · PHASE3 · COMPLETED · sponsor: **Fondazione EMN Italy Onlus** · enrollment: 660 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Melphalan, Prednisone, Lenalidomide
- **DRUG:** Cyclophosphamide, Prednisone, Lenalidomide
- **DRUG:** Lenalidomide, dexamethasone

## Key facts

- **NCT ID:** NCT01093196
- **Lead sponsor:** Fondazione EMN Italy Onlus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-11
- **Final completion:** 2024-07-01
- **Target enrollment:** 660 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093196, "Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01093196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*